Labcorp Launches H5 Bird Flu Test
Labcorp introduced a molecular H5 bird flu test to help diagnose human infections with the H5N1 virus, enhancing public health response.
Read MorePosted by Andy Lundin | Dec 17, 2024 | Emerging & Zoonotic Diseases, Point-of-Care |
Labcorp introduced a molecular H5 bird flu test to help diagnose human infections with the H5N1 virus, enhancing public health response.
Read MorePosted by Andy Lundin | Dec 13, 2024 | Tuberculosis |
WHO granted prequalification to a tuberculosis molecular diagnostic test that delivers rapid detection of TB and drug resistance.
Read MorePosted by Andy Lundin | Dec 2, 2024 | Company News |
QIAGEN is relocating its QIAstat-Dx operations to a new facility in Barcelona to strengthen its syndromic testing capabilities.
Read MorePosted by Andy Lundin | Nov 22, 2024 | Emerging & Zoonotic Diseases |
Researchers developed an advanced diagnostic kit enabling rapid detection and differentiation of H5N1 avian influenza strains.
Read MorePosted by Andy Lundin | Nov 19, 2024 | Point-of-Care, Sample Storage & Management |
Fluxergy is collaborating with NIAID to enhance molecular testing and sample preparation on its innovative platform.
Read More